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Abstract
Background/Aim: The human intestinal microbiota plays an important role in modulation of mucosal immune responses.
To study interactions between intestinal epithelial cells (IECs) and commensal bacteria, a functional metagenomic approach
was developed. One interest of metagenomics is to provide access to genomes of uncultured microbes. We aimed at
identifying bacterial genes involved in regulation of NF-kB signaling in IECs. A high throughput cell-based screening assay
allowing rapid detection of NF-kB modulation in IECs was established using the reporter-gene strategy to screen
metagenomic libraries issued from the human intestinal microbiota.
Methods: A plasmid containing the secreted alkaline phosphatase (SEAP) gene under the control of NF-kB binding
elements was stably transfected in HT-29 cells. The reporter clone HT-29/kb-seap-25 was selected and characterized. Then, a
first screening of a metagenomic library from Crohn’s disease patients was performed to identify NF-kB modulating clones.
Furthermore, genes potentially involved in the effect of one stimulatory metagenomic clone were determined by sequence
analysis associated to mutagenesis by transposition.
Results: The two proinflammatory cytokines, TNF-a and IL-1b, were able to activate the reporter system, translating the
activation of the NF-kB signaling pathway and NF-kB inhibitors, BAY 11-7082, caffeic acid phenethyl ester and MG132 were
efficient. A screening of 2640 metagenomic clones led to the identification of 171 modulating clones. Among them, one
stimulatory metagenomic clone, 52B7, was further characterized. Sequence analysis revealed that its metagenomic DNA
insert might belong to a new Bacteroides strain and we identified 2 loci encoding an ABC transport system and a putative
lipoprotein potentially involved in 52B7 effect on NF-kB.
Conclusions: We have established a robust high throughput screening assay for metagenomic libraries derived from the
human intestinal microbiota to study bacteria-driven NF-kB regulation. This opens a strategic path toward the identification
of bacterial strains and molecular patterns presenting a potential therapeutic interest.
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Introduction
The intestinal tract harbors trillions of commensal bacteria
representing over a thousand species and encoding over one
hundred and fifty fold more genes than the human genome.
During the past decade, the gut microbiota was revealed as
providing an important functional contribution to its host
physiology and in maintenance of health [1]. However, the
understanding of these functional interactions is in its infancy. The
limitation imposed by the inability to cultivate the majority of the
indigenous microbial species is now bypassed with the metage-
nomic approach [2]. Metagenomic libraries already allowed
sequence-based explorations of the human intestinal microbiome
that drew up microbial genomic and genetic diversity [3,4,5].
Furthermore, the metagenomic approach has been used for some
functional investigations of gut microbial communities [6,7,8,9],
however, these applications are few compared to metagenomic
studies of other environmental ecosystems [for review: 2,10].
The human intestinal microbiota has been shown to participate
in epithelium maturation, host nutrition and protection against
pathogens [11] and more recently in regulating gut epithelial cells
proliferation [12], host energy metabolism [13] and immune
responses [14], thus reflecting the symbiotic and beneficial
crosstalk between intestinal epithelial cells (IECs) and intestinal
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ota in diseases such as allergies [15], inflammatory bowel disease
(IBD) [16] and cancer [17]. This evidence unmasks the unwanted
face of the microbiota and stresses the importance of an accurate
equilibrium between microbes and mucosal immune system.
Indeed, the mucosa has the challenge to sense pathogens while
being unresponsive to food antigens and commensals, in order to
maintain integrity and normal function of the intestine. Tradi-
tionally, immune responses in the gut involved the gut-associated
lymphoid tissue (GALT), but it is now established that IECs are
also an essential component in innate immunity [18]. Theses cells
can directly sense commensal bacteria and pathogens via pattern
recognition receptors (PRRs), including Toll-like receptors (TLRs)
and Nod-like receptors (NLRs). These receptors are specialized in
the recognition of conserved bacterial and viral structures and
generally activate proinflammatory pathways warning the host
about infections [19].
Immune and inflammatory responses in the gut involve the
transcription factor NF-kB. This DNA binding protein is the
transcriptional factor of an evolutionarily conserved regulatory
pathway that drives expression of a large number of genes involved
in proinflammatory processes at the site of infection or tissue
damage. It also controls cell survival, proliferation and differen-
tiation gene expression induced by a wide range of noxious stimuli
[20,21]. Recent studies have demonstrated that NF-kB signaling is
a critical element of the homeostatic immuno-inflammatory
function in the gut [22] and both deficiency in, or hyperactivation
of this transcription factor are linked with pathologies such as
chronic IBD or obesity [23,24,25,26,27].
Thus, determining the factors that regulate this key pathway is
of great scientific and clinical interest. In the present study, we
present the development of a high throughput functional screening
method of metagenomic libraries designed to explore novel NF-kB
modulatory potentials within the human intestinal microbiota. A
cellular tool, based on the reporter gene strategy, was obtained
using the intestinal epithelial cell line HT-29, and was validated
and applied for screening of a metagenomic library issued from the
intestinal microbiota of Crohn’s disease (CD) patients [4]. This
strategy opens a way toward identification of bacterial species and
effectors involved in the interaction with IECs via NF-kB signaling.
Materials and Methods
Cell culture
To construct the reporter model, we selected the human
colorectal carcinoma cell line HT-29 that was obtained from the
American Type Culture Collection (Rockville, MD). HT-29 cells
were grown in RPMI 1640 medium (Sigma) with 2 mM L-
glutamine, 50 IU/mL penicillin, 50 mg/mL streptomycin and
10% heat-inactivated fetal calf serum (FCS - Lonza) in a
humidified 5% CO2 atmosphere at 37uC. The THP-1 blue
TM
CD14+ cells used as control for TLRs responses were obtained
from Invivogen and used according to the manufacturer’s
instruction.
Construction of stable NF-kB reporting HT-29 cells
Stable HT-29 transfectants containing the secreted alkaline
phosphatase (SEAP) reporter gene were obtained after cell
transfection with the reporter plasmid pNiFty2-SEAP (Invivogen),
which contains SEAP as reporter gene and zeocin as resistance
antibiotic gene, using TFX-50
TM (Promega) following manufac-
turer’s instruction. Cells were cultured for 3 weeks under zeocin
(50 mg/mL) selection and cloned. The HT-29/kb-seap-25 clone
was selected for its response to 10 ng/ml of TNF-a after 24 h
stimulation.
Analyses of NF-kB activation
For each experiment, HT-29/kb-seap-25 reporter cells were
seeded at 50 000 cells per well, into 96-wells plates and incubated
24 hours before stimulation. Cells were stimulated with 10 mlo f
each tested substances for a final volume per well of 100 ml.
SEAP in the supernatant was revealed using Quanti-Blue
TM
reagent (Invivogen) according to the manufacturer’s protocol and
quantified as OD at 655 nm. All measurements were performed
using a microplate reader (Infinite 200, Tecan).
NF-kB inhibitors
NF-kB inhibitors caffeic acid phenethyl ester (CAPE), BAY 11-
7082 ((E)3-[(4-methylphenyl)sulfonyl]-2-propenenitrile) and
MG132 (ZLeu-Leu-Leu-H) were provided by Calbiochem. Cells
were stimulated with a concentration range of each inhibitor in the
presence or absence of 10 ng/mL of TNF-a.
TLRs analysis
TLRs ligands response profiles. The TLR response profile
was determined using the TLR1-9 agonist kit (Invivogen)
according to manufacturer’s instruction. Ligands and working
concentrations are for TLR1/2: Pam3CSK4 (1 mg/mL); TLR2:
Heat Kiled Listeria monocytogenes (10
8 cells /mL); TLR3: Poly(I:C)
(10 mg/mL); TLR4: E. coli K12 LPS (10 mg/mL); TLR5: Salmonella
typhimurium Flagellin (10 mg/mL); TLR6/2: FSL1 (1 mg/mL);
TLR7: Imiquimod (1 mg/mL); TLR8: ssRNA40 (1 mg/mL);
TLR9: ODN2006 (5 mM). TLRs expression profiles by
flow cytometry. Reporter cells were washed with 2% FCS in
phosphate-buffered saline (PBS) and stained with TLRs antibodies
(Ab) for 30 min at 4uC. Ab for human TLR2, TLR3, TLR4, and
TLR9 were obtained from eBioscience. TLR5, TLR6 and TLR7
Ab were from Imgenex and TLR8 antibody from Axxora. Isotype
matched Ab were used as negative controls and all antibodies used
were originally coupled with Phycoerythrin (PE). After incubation,
cells were washed again with PBS+2% FCS and fixed (CellFix –
BD bioscience) prior to analysis using a Becton-Dickinson
FACSCalibur flow cytometer and CellQuest software (BD
Biosciences). For evaluation of total (surface plus intracellular)
expression, cells were fixed and permeabilized using CytoFix/
CytoPerm (BD Pharmingen). For each measurement, 3610
4 cells
were analysed.
High throughput screening of metagenomic clones
We used the HT-29/kb-seap-25 cells to screen a metagenomic
library issued from the intestinal microbiota of CD patients [4] for
NF-kB modulatory capacities. The screened library consisted of
2640 Escherichia coli (E. coli) DH10B clones bearing fosmids with
metagenomic inserts of 40 kb length approximately randomly
selected from a global library of 25 000 clones. E. coli bearing a
fosmid without a metagenomic insert was used as control (referred
as metagenomic controls). Metagenomic clones were cultured for
24 hours in lysogeny broth (LB) medium in 96 wells plates. Then
OD600 nm was measured and given as a raw value. It is important
to precise that this OD value corresponds to a measurement in 96
well plates and a culture volume of 150 ml. In these conditions,
growth stationary phase of E. coli started at 0.4 OD approximately.
Bacterial cells were broken with glass beads (106 mm, Sigma) in a
mixer mill (15 oscillations/second, two cycles of 90 sec). The
suspension was filtered by centrifugation at 4uC through a 0.2 mm
microplate filter (Corning) and added to HT-29/kb-seap-25
Metagenomics and NF-kB
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of the reporter cells, addition of lysates and SEAP activity
measurement were performed using a robotic pipetting worksta-
tion (Microlab Star, Hamilton). Ten selected metagenomic clones,
5 stimulatory and 5 inhibitory, were grown further in 8
independent cultures and tested to validate their effect.
Characterization of the stimulatory clone 52B7
A preparation of supernatant and lysed pellet was done to
determine the active culture fraction of 52B7. Supernatant of an
overnight culture grown at 37uC was collected after filtration on a
0.2 mm filter. After centrifugation of the bacterial culture at
5000 g/10 min, pellet was resuspended in RPMI and bacterial
cells were broken by shaking with glass beads in a mixer mill as
described above.
The 52B7 fosmid was purified using the NucleoBond extraction
kit (Macherey-Nagel) and the DNA insert was sequenced
(Genoscope, Evry, France). The sequence is available on GenBank
(accession number HQ231916). Potential transcription units were
detected using SoftBerry’s software FGENESB (http://linux1.
softberry.com/berry.phtml). Potential ORFs contained in the
40 kb insert were determined using GeneMark.hmm for prokary-
otes (http://exon.biology.gatech.edu/gmhmm2_prok.cgi) and
FGENESB. Both analyses were performed using Bacteroides
thetaiotaomicron VPI-5482 as model organism. The output predicted
protein sequences were further blasted in order to have
phylogenetic and function estimation. The final phylogenetic
assignment was expressed in percentage of total genes length
coverage. The original host was searched using Blastn and the
microbial genome database on the NCBI.
To determine the potential gene(s) involved in the stimulatory
effect of 52B7, fosmid transposition was performed as previously
described [6] using the EZ-Tn5
TM ,KAN-2. kit according to
manufacturer instructions (Epicentre). Two hundred transposed
clones of 52B7 were picked and tested for a revertant phenotype
toward NF-kB activation. Three transposed clones with a
revertant behaviour were validated and transposon insertion site
in the metagenomic insert was determined by sequencing (Beck-
man Coulter Genomics) using primers homologous to the ends of
the transposon (Epicentre).
Statistical analysis
Presented results were representative of a minimum of 3
independent experiments. Results were expressed as mean 6
standard deviation of triplicate measurements. Data were analyzed
by Student’s t test.
Results
Development and characterization of the NF-kB reporter
system in HT-29 cells
After transfection and culture of several clones under zeocin
selection, we selected the best responding reporter clone, HT-29/
kb-seap-25, which displayed a high signal upon TNF-a stimulation
and a high ratio between unstimulated and stimulated states
(Fig. 1a). To determine whether the reporter gene in the selected
reporter clone reflects well the regulation of the NF-kB signaling
pathway, we characterized extensively its response to known NF-
kB modulating molecules, including proinflammatory cytokines,
chemical inhibitors and TLRs agonists.
The two proinflammatory cytokines, TNF-a and IL-1b, were
able to induce expression of the reporter genes in a dose
dependent manner (Fig. 1b). As expected, the induction was
stronger with TNF-a than IL-1b and did not reach saturation even
at the highest dose used (100 ng/mL), while IL-1b was saturated
at 10 ng/mL (Fig. 1b). We examined the kinetics of activation of
our NF-kB reporter systems by incubating the cells with TNF-a
(10 ng/mL) at different times (Fig. 1c). Activity of the reporter
clone HT-29/kb-seap-25 increased in a time dependent manner,
with a maximum effect occurring after 24 hours stimulation. A
weak activity was detected after 4 hours and continued to increase
throughout the experiment (Fig. 1c).
Three chemical inhibitors acting at different level of the NF-kB
pathway were tested. Reporter cells were incubated for 24 hours
with different concentrations of CAPE, BAY-117082 and MG132,
and co-treated with TNF-a. NF-kB activation was reduced by
50% in cells treated with 14.2 mM of BAY 11-7082 (Fig. 1d) or
22.2 mg /mL of CAPE (Fig. 1f). In the case of MG132, IC50 was
0.2 mM (Fig. 1e). No effect on the reporter system was observed
when the cells were treated with the solvent (DMSO) alone (not
shown).
TLRs expression and response to TLRs ligands
The TLRs have an immunological sensing role for bacterial,
fungal, viral and parasitic organisms. Therefore, we first examined
the presence of 8 different TLRs in the HT-29/kb-seap-25 cells
(Fig. 2a and 2b). TLR5 was expressed by HT-29 cells however no
TLR2 and few TLR4, TLR6 and TLR9 were detected at the cell
membrane (MFI given in Table S1). Interestingly, TLR3
expression was detected at cell membrane, but also in the
endolysosomal compartment as revealed after permeabilization.
As expected, TLR7, TLR8 and TLR9 were only found in the
intracellular compartment.
When we tested induction of the reporter gene by 9 different
TLRs ligands, we found that TLR3, TLR4 and TLR5 ligands
were active, concordantly with the presence of the cognate
receptors (Fig. 2b). S. typhimurium flagellin was highly stimulatory,
therefore correlating with TLR5 expression in these cells, while E.
coli K12 lipopolysaccharide (LPS) and Poly-IC, ligands for TLR4
and TLR3, respectively, were also stimulatory but to a lesser
degree. Despite the fact that TLR7, 8 and 9 were detected by flow
cytometry in the cytoplasm of HT-29/kb-seap-25 cells, no SEAP
activity was detected when the cells were stimulated with their
respective agonist, imiquimod, ssRNA and CpG-ODN.
Finally, the agonists were tested for control on THP-1 blue
TM
CD14+ which is an NF-kB reporter monocytic cell line
(Invivogen). We observed that THP-1 responded to the stimula-
tion with all tested agonists except those which receptors (TLR3, 7,
8 and 9) are located in the intracellular compartment (data not
shown).
Seeking for modulatory metagenomic clones
NF-kB reporter cells were constructed in view of performing high
throughput screening of NF-kB modulation capabilities within
metagenomic libraries issued from human intestinal microbiota. A
first screening usingthe HT-29/kb-seap-25 reporter clone wasdone
on 2640 metagenomic clones from a library prepared with the fecal
microbiota of CD patients [4]. Results (Fig. 3a) are represented as a
plot of reporter gene activity (normalized to that of the
metagenomic control) and growth level for each metagenomic
clone. In a OD range between 0.4 and 0.8, growth of the
metagenomic control was not correlated with NF-kB activity.
A vast majority (93.5%) of the 2640 tested clones had no
significant different effect on NF-kB activity as compared to the
controls. Interestingly, 22 lysates (0.8%) enhanced the reporter
system activity while 149 lysates (5.6%) down-activated it. We
decided to validate 10 clones producing the highest enhancing or
inhibitory effect (circled on Fig. 3a). These 10 clones were
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the HT-29/kb-seap-25 cells (Fig. 3b). All of the 5 activating clones
(43C8; 52B7; 90B4; 90C4 and 122B8) displayed high stimulatory
effects that were significantly different from the control (p,0.01).
No inhibitory clones affected the expression of the reporter gene
to an extent comparable to that of the 5 most stimulatory clones
(Fig. 3a). The 5 inhibitory clones selected (31B2; 38B10; 90H7;
122A8 and 123H11) were nevertheless submitted to the validation
step and we found one having a very significant and reproducible
effect (122A8, Fig. 3b).
This demonstrates that our screening system can successfully
identify bacterial metagenomic clones able to modulate NF-kB
signaling in HT-29. We also obtained a Caco-2 reporter clone
(Caco-2/kb-seap-7) that was characterized similarly to HT-29, but
was not used for the present screening (see Method S1, Fig. S1 and
Table S5). However, it is noteworthy that on Caco-2 reporter cells,
the 10 selected lysates were without effects suggesting potential cell
line specificity (data not shown).
Toward the identification of a new bacterial stimulatory
mechanism of NF-kB
For further investigation, we decided to focus on the stimulatory
clone 52B7. Metagenomic DNA insert of 52B7 (37,006 base pairs
long) contains 43 genes and 23 transcriptional units according to
GeneMark.hmm and FGENESB predictions (Table S2). The total
predicted genes length represents 80.8% of the total insert length
(Table S4). No relatives were found in NCBI bacterial genome
Figure 1. Selection and characterization of a NF-kB reporter clone of HT-29. a. Response of reporter clones to TNF-a stimulation (10 ng/
mL). The signal level (OD655 nm) and the ratio of signal with and without stimulation are displayed. A highly efficient clone HT-29/kb-seap-25 is
highlighted (arrow). b. Dose-response of HT-29/kb-seap-25 cells to increasing concentrations of TNF-a or IL-1b. Reporter gene activity was measured
after 24 hours stimulation. c. Kinetic of HT-29/kb-seap-25 cells response to incubation with TNF-a (10 ng/mL) for different times. d–f. Inhibition of the
TNF-a induction of the NF-kB reporter gene in the HT-29/kb-seap-25 cells. Three inhibitor, BAY 11-7082 (d.), MG132 (e.) and CAPE (f.) were tested in
presence (solid line) or absence (doted line) of TNF-a (10 ng/mL). Cells were analyzed for NF-kB activity after 24 hours. In all cases, SEAP activity was
measured in the supernatant using Quanti-Blue
TM (Invivogen) and was expressed as OD at 655 nm.
doi:10.1371/journal.pone.0013092.g001
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PLoS ONE | www.plosone.org 4 September 2010 | Volume 5 | Issue 9 | e13092Figure 2. TLRs expression and response to TLRs agonists. Cell surface (a.) and intracellular (b.) expression of different TLRs as assessed by flow
cytometry using antibodies to TLR2 to TLR9 (from BD Biosciences) in HT-29/kb-seap-25 cells using a FACScalibur (BD Biosciences). Controls are
represented in red. c. Effect of various TLRs ligands on reporter gene activity quantified as OD measured at 655 nm by HT-29/kb-seap-25 cells
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52B7 insert showed that it is probably issued from a Bacteroides
genus member (98.5% of predicted genes coverage), the most
closely related cultivated strain being B. vulgatus ATCC 8482 with
42% of predicted genes coverage (Table S3 and Table S4).
We then identified the most active fraction by testing separately
supernatant and lysed pellet. We observed that the stimulatory
effect was mainly present in the supernatant while only a weak
activity was detected in the lysed pellet (data not shown).
Moreover, we also confirmed that 52B7 supernatant significatively
induced IL-8 secretion in both parental HT-29 and HT-29/kb-
seap-25 reporter cells as compared with the metagenomic control
(Method S2 and Fig. S2). Therefore, we managed to identify the
gene(s) or loci responsible for the stimulatory effect and performed
mutagenesis on the fosmid by insertion of transposon EZ-TN5.
Out of 192 mutants, we obtained 3 transposed clones from 52B7
of which the supernatant did not produce any more stimulation of
NF-kB (Fig. 4a). Insertion regions of the transposons were
determined by sequencing. Analysis of both insert annotation
and sequences from the EZ-TN5 transposon revealed that in
52B7/A and 52B7/C, the transposons were inserted in the same
gene encoding an ATP-binding cassette (ABC) transporter
permease (Fig. 4b and 8
th gene in Table S2). In 52B7/B
transposon targeted the 38
th gene, which encodes for a putative
lipoprotein with unknown function (Table S2). The two targeted
genes were part of two putative distinct transcription units (Table
S2). Each of the two targeted insert loci was therefore involved in
52B7 stimulatory effect of NF-kB in HT-29.
Discussion
We have presented the construction and validation of a cell-
based screening system to study NF-kB modulation in IECs and its
first utilization within screening of metagenomic libraries from the
human gut microbiota. Using the reporter gene strategy, we have
obtained an HT-29 reporter cell clone (HT-29/kb-seap-25) that
allows rapid examination of NF-kB activity regulation. A
validation of the selected reporter clone was performed to check
the robustness of its response to known activators or inhibitors of
NF-kB pathway. We observed a dose-dependent stimulation of
NF-kB in HT-29 clone upon treatment with the proinflammatory
cytokines TNF-a and IL-1b. These observations are classical and
well described in the literature [28]. We tested 3 different NF-kB
inhibitors, each one acting at different levels of the NF-kB
pathway. Previous studies demonstrated that the proteasome
inhibitor MG132 blocks TNF-a-induced degradation of IkBa and
leads to the accumulation of phosphorylated IkBa [29]. Since it
inhibits proteasome activity, MG132 is not a specific NF-kB
inhibitor but is widely used as such. CAPE is an active molecule
purified from honeybee hives and was also described as an anti-
inflammatory molecule acting at the level of DNA binding in
human histiocytic cell line [30]. BAY 11-7082 is an irreversible
inhibitor of IkBa phosphorylation thereby sequestering NF-kBi n
an inactive state in the cytoplasm and preventing activation of
downstream signaling [31]. These three molecules were efficient in
the HT-29 reporter cells.
The gut epithelium is exposed to numerous microbes without
developing uncontrolled inflammation. One of the proposed
mechanisms explaining such epithelium tolerance towards com-
mensals is its hypo-responsiveness to bacterial patterns involving
TLRs signaling cascade. For example, Toll inhibitory protein
(Tollip) was shown to inhibit IL-1R activated kinase (IRAK)
activation, resulting in loss of TLR2 and TLR4 response in the gut
[32,33]. In addition, the luminal surface seems to be devoid of
TLR2 and 4, their expression being confined to crypt cells [34]. It
is noteworthy that characterization of TLRs showed unrespon-
siveness of our HT-29 and Caco-2 reporter cells toward agonists of
the bacterial cell wall components receptors TLR1/2, TLR2 and
TLR6/2. Using mRNA and protein analysis, other laboratories
[35,36] showed that both cell lines expressed very low levels of
TLR2 mRNA as compared to a TLR2-ligand responsive
monocyte cells THP-1. TLR1 and 6 mRNA were not expressed
by Caco-2 whereas HT-29 did. In addition, it was demonstrated
that these cell lines expressed increased levels of Tollip, the TLR2
signaling inhibitor, which could explain the lack of response
obtained with TLR1/2, TLR2 and TLR 6/2 agonists. Challeng-
ing HT-29 cells with LPS alone resulted in a small but significant
induction of NF-kB-dependent reporter gene activity which is
consistent with previous results demonstrating that parental HT-
29 line expresses small levels of TLR4 mRNA and protein [35,37],
and high level of Tollip [38]. By contrast, we found that HT-29
reporter cells were strongly responsive to flagellin treatment.
TLR5 recognition of bacterial flagellin from both Gram-positive
and Gram-negative bacteria was previously reported [39] and was
described to be constitutively expressed at the apical and
basolateral side in HT-29 [40].
Nucleic acid recognition is possible via TLR3, TLR7, TLR8
and TLR9, which are classically located in the intracellular
endosomal compartment. Following treatment with Poly-I:C, a
synthetic analogue of double stranded RNA, which is recognized
by TLR3 [41], NF-kB activation was detected in HT-29 cells but
not in THP-1 control reporter cells. This difference could be
linked to the localization of TLR3 in HT-29. Indeed expression
patterns described for this cell line suggest localization in both
cytoplasm and cell membrane [34,42,43], a finding that we
confirmed by flow cytometry. In our hands, TLR7, TLR8 and
TLR9 agonists did not induce NF-kB activation in HT-29, Caco-2
nor in THP1 reporter cell lines.
Validation of our reporter screening tools showed reproducible
responses consistent with the literature and the reporter gene
strategy proposed is robust for high throughput identification of
bacterial modulatory potentials within metagenomic libraries.
Metagenomic is a recent approach designed to uncover novel
genes and related functions [2]. However, this method can identify
only a small proportion of genes from the natural pool due to
cloning and heterologous expression limitations in E. coli.
Nevertheless, E. coli is a reliable host since it was shown to be
able to express up to 40% of the functional potential from
randomly cloned environmental DNA [44]. To fulfill these
limitations, work is in progress to generate libraries in a Gram +
recipient host. Nevertheless, the methodology presented allowed
us to identify 171 metagenomic clones able to modulate NF-kB
pathway. Here we presented the first results obtained on the
characterization of the stimulatory metagenomic clone 52B7.
The 52B7 insert is issued from a probably unknown Bacteroides
strain and encodes number of hypothetical proteins with unknown
functions. This demonstrates the importance of the functional
metagenomic approach in a better understanding of the
assessed after 24 hours stimulation. Ligands are for TLR1/2: Pam3CSK4 (1 mg/mL); TLR2: Heat Kiled Listeria monocytogenes (10
8 cells /mL); TLR3:
Poly(I:C) (10 mg/mL); TLR4: E. coli K12 LPS (10 mg/mL); TLR5: Salmonella typhimurium Flagellin (10 mg/mL); TLR6/2: FSL1 (1 mg/mL); TLR7: Imiquimod
(1 mg/mL); TLR8: ssRNA40 (1 mg/mL); TLR9: ODN2006 (5 mM). All ligands are from Invivogen. * = p,0.05.
doi:10.1371/journal.pone.0013092.g002
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PLoS ONE | www.plosone.org 6 September 2010 | Volume 5 | Issue 9 | e13092Figure 3. Screening of a metagenomic library for NF-kB modulation using HT-29 reporter cells. a. First screening of 2640 clones of a
metagenomic library prepared from the fecal microbiota of CD patients. Lysates were added at 10% vol/vol to HT-29/kb-seap-25. NF-kB activity
(expressed as OD655 nm) was normalized to the mean activity of the metagenomic controls (E. coli DH10B + empty fosmid; represented in black).
Bacteria growth was expressed as OD600 nm. Standard deviation of the control is represented as horizontal doted line and circle dots represent the 10
active lysates selected for further validation. b. Validation of the effect of 5 activating and 5 inhibiting clones. Metagenomic clones were grown in 8
independent cultures and tested on HT-29/kb-seap-25. Reporter gene activity was assayed after 24 hours stimulation. NF-kB activity (expressed as
OD655 nm) was normalized to that of the control (E. coli DH10B + empty fosmid). ** p,0.01 as compared to control.
doi:10.1371/journal.pone.0013092.g003
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their host. Interestingly, the closest relative species was B. vulgatus,a
commensal bacteria previously found to be more abundant in CD
patients than in healthy subjects [45]. Moreover, presence of
antibodies against B. vulgatus was reported in CD patients [46].
However no mechanism was yet proposed to explain a possible
implication of B. vulgatus in CD. Concerning the 52B7 insert, no
proteins already known to activate NF-kB signaling (such as a
TLR ligand) were detected, suggesting the involvement of
potentially new stimulatory effectors.
Using mutagenesis by transposition, we identified two different
candidate loci responsible for the stimulatory effect of NF-kBo n
HT-29. The first locus, related to an efflux ABC-type transport
system, includes a permease particularly targeted by the
transposition experiments and the second locus highlighted
includes a putative lipoprotein with unknown function. The
contribution of the 2 loci on the stimulatory effect still needs to be
elucidated. According to the literature, some ABC transporter
proteins ensuring lipoprotein trafficking in Gram-negative bacteria
were described [47]. In addition, lipoproteins from pathogenic
bacteria are known inducer of immune responses during infection,
generally through interaction with TLR2 [48,49]. It is therefore
tempting to assume a potential mechanism in which the efflux
ABC transporter would drive the release of the putative
lipoprotein, the latter being the bacterial effector responsible for
activation of NF-kB in HT-29, potentially through a TLR2-
independent manner since this receptor is absent. Future
investigations will be necessary to precisely determine bacterial
Figure 4. Identification of the bacterial genes involved in the stimulatory effect of 52B7. a. Effect of 3 selected transposed clones with
revertant behavior. Filtered culture supernatants were added at 10% vol/vol to HT-29/kb-seap-25. Control corresponds to E. coli DH10B bearing
empty fosmid. * = p,0.05. b. Sequence annotation and localization of transposon insertion sites. EZ-TN5 transposon is represented as a grey box. A,
B and C corresponds to the insertion region of the transposed clones 52B7/A, 52B7/B and 52B7/C, respectively.
doi:10.1371/journal.pone.0013092.g004
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potential implication in the existing relationship between some
commensals (as B. vulgatus) and pathogenesis of IBD.
Our approach provided other excellent candidate metagenomic
clones for investigation of novel host-commensal interaction
mechanisms and these clones are currently being characterized
using a similar strategy.
In future work, the NF-kB reporter cell lines will be used in the
automated screening of new metagenomic libraries in the frame of
the MetaHIT project. This approach targeting NF-kB pathway is
currently under development for other signaling pathways
including AP1, p53, c-Myc and PPARc, as well as for genes of
interest including Thymic Stromal Lymphopoietin (TSLP) and
angiopoietin-like protein 4/fasting-induced adipose factor
(Angptl4/FIAF). We think that our functional metagenomic
strategy will allow identification of genes that human-associated
intestinal microbes may use to affect expression of genes and
pathways of their host, thus opening new avenues towards a better
understanding of microbiota-host interactions and potential
development of new probiotics or therapeutic molecules.
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Figure S1 Characterization of Caco-2/kb-seap-7 cell clone. a.
Dose response. Caco-2/kb-seap-7 cells were stimulated with
increasing concentration of TNF-a or IL-1b. Reporter gene
activity quantified as OD measured at 655 nm was measured after
24 hours stimulation. b. Response to TLRs ligands. Caco-2/kb-
seap-7 clone was stimulated with different TLRs agonists as
described in Figure 2. NF-kB activity was measured after 24 hours
stimulation. c–e. Dose-dependent effect of BAY 11-7082 (c),
MG132 (d) and CAPE (e) on NF-kB inhibition was tested in
presence (solid line) or absence (doted line) of IL-1b. Culture
supernatant were analyzed for NF-kB activity after 24 hours
treatment. Results are mean 6 standard deviation of triplicate
measurements for one representative of three independent
experiments.
Found at: doi:10.1371/journal.pone.0013092.s001 (0.24 MB TIF)
Figure S2 52B7 supernatant stimulates IL-8 secretion in HT-29
cells. Effect of filtered bacterial supernatant of 52B7 on parental
HT-29 (a) and HT-29/kb-seap-25 (b). Supernatant was added at
10% vol/vol and IL-8 secretion was measured after 24 hours
incubation. Control corresponds to culture supernatant from the
metagenomic control (E. coli bearing empty fosmid). Bacteria
growth medium corresponds to LB. TNF-a (10 ng/mL) was used
as positive control. Results are expressed as mean 6 standard
deviation. One representative experiment of 2 independent
experiments is shown. * = p,0.05.
Found at: doi:10.1371/journal.pone.0013092.s002 (0.25 MB TIF)
Table S1 TLRs expression in HT-29/kb-seap-25. Results are
expressed as MFI (Mean Fluorescence Intensity).
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insert. * T.U = transcription unit. Length is expressed in bp (base
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Table S5 TLRs expression in Caco-2/kb-seap-7. Results are
expressed as MFI (Mean Fluorescence Intensity).
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